Characterization of adrenomedullin in non-human primates

Enrique Zudaire1, Alfredo Martínez, Laurent L Ozbun

  • 1Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. zudairee@mail.nih.gov

Insights

Monkey adrenomedullin (AM) gene structure and expression were analyzed. High homology to human AM suggests monkeys are a valuable model for AM-targeted drug development and pre-clinical studies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Adrenomedullin (AM) is a peptide hormone implicated in various human diseases.
  • Understanding the genetic and expression profile of AM in non-human primates is crucial for translational research.

Purpose of the Study:

  • To characterize the gene structure, organ distribution, and regulated expression of adrenomedullin (AM) in monkeys.
  • To evaluate the potential of the monkey as an animal model for studying AM-related pathophysiology and drug development.

Main Methods:

  • Gene structure analysis and chromosomal localization.
  • Real-time PCR and immunohistochemistry for organ distribution and expression analysis.
  • Investigating mRNA upregulation under specific stimuli (hypoxia, TGF-β1, retinoic acid, dexamethasone).

Main Results:

  • The monkey AM (mAM) gene is on chromosome 9, encoding a preprohormone with peptides identical to human AM.
  • mAM is widely expressed across monkey organs, with similar plasma levels to humans.
  • mAM mRNA significantly upregulated in response to hypoxia, TGF-β1, all-trans-retinoic acid, and dexamethasone.

Conclusions:

  • The monkey AM gene exhibits high homology to the human counterpart.
  • Monkeys serve as a suitable pre-clinical model for pharmacological studies targeting adrenomedullin.
  • This research provides a foundation for future AM-focused therapeutic interventions.